Joseph W. Chow

8.0k total citations · 1 hit paper
74 papers, 6.1k citations indexed

About

Joseph W. Chow is a scholar working on Infectious Diseases, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Joseph W. Chow has authored 74 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 29 papers in Molecular Medicine and 18 papers in Molecular Biology. Recurrent topics in Joseph W. Chow's work include Antimicrobial Resistance in Staphylococcus (33 papers), Antibiotic Resistance in Bacteria (29 papers) and Bacterial Identification and Susceptibility Testing (18 papers). Joseph W. Chow is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (33 papers), Antibiotic Resistance in Bacteria (29 papers) and Bacterial Identification and Susceptibility Testing (18 papers). Joseph W. Chow collaborates with scholars based in United States, Spain and United Kingdom. Joseph W. Chow's co-authors include Marcus Zervos, Victor L. Yu, Susan Donabedian, Don B. Clewell, David M. Shlaes, Marilyn M. Wagener, L A Thal, Mary Beth Perri, John P. Quinn and David C. Hooper and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Annals of Internal Medicine.

In The Last Decade

Joseph W. Chow

74 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy

1991 706 citations Joseph W. Chow, John P. Quinn et al. profile →

Peers

Countries citing papers authored by Joseph W. Chow

Since Specialization

Citations

This map shows the geographic impact of Joseph W. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph W. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph W. Chow more than expected).

Fields of papers citing papers by Joseph W. Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph W. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph W. Chow. The network helps show where Joseph W. Chow may publish in the future.

Co-authorship network of co-authors of Joseph W. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph W. Chow. A scholar is included among the top collaborators of Joseph W. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph W. Chow. Joseph W. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme 2020 ·Drug Safety ·Karen Cheng, Paul Newell, Joseph W. Chow, Helen Broadhurst, David J. Wilson, Katrina Yates, Angela Wardman	18
2	A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia 2010 ·The Pediatric Infectious Disease Journal ·Johan Maertens, Luís Madero, Anne F. Reilly, Thomas Lehrnbecher, Andreas H. Groll, Hasan S. Jafri, Michael Green, Joseph J. Nania, Michael Bourque, (unknown), Kim M. Strohmaier, (unknown), Nicholas A. Kartsonis, Joseph W. Chow, Carola A.S. Arndt, Ben E. dePauw, Thomas J. Walsh	101
3	Source of Phosphate in the Enzymic Reaction as a Point of Distinction among Aminoglycoside 2″-Phosphotransferases 2009 ·Journal of Biological Chemistry ·Márta Tóth, Joseph W. Chow, Shahriar Mobashery, Sergei B. Vakulenko	37
4	SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS 2009 ·The Pediatric Infectious Disease Journal ·Theoklis E. Zaoutis, Thomas Lehrnbecher, Andreas H. Groll, William J. Steinbach, Hasan S. Jafri, Johan Maertens, Angela Ngai, Joseph W. Chow, (unknown), Kim M. Strohmaier, Michael Bourque, Susan K. Bradshaw, (unknown), Nicholas A. Kartsonis	29
5	In Vitro Susceptibilities of Aerobic and Facultatively Anaerobic Gram-Negative Bacilli Isolated from Patients with Intra-Abdominal Infections Worldwide: 2005 Results from Study for Monitoring Antimicrobial Resistance Trends (SMART) 2008 ·Surgical Infections ·Fernando Baquero, Po‐Ren Hsueh, David L. Paterson, Flávia Rossi, Grant V. Bochicchio, G. Gallagher, (unknown), (unknown), Kathleen McCarroll, Murray A. Abramson, Joseph W. Chow	51
6	Aminoglycoside 2″-Phosphotransferase Type IIIa from Enterococcus 2008 ·Journal of Biological Chemistry ·Adriana Badarau, Qicun Shi, Joseph W. Chow, Jaroslav Zajíček, Shahriar Mobashery, Sergei B. Vakulenko	11
7	Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy 2007 ·Diagnostic Microbiology and Infectious Disease ·Mark J. DiNubile, Ian R. Friedland, Christina Y. Chan, Mary Motyl, Hilde Giezek, Kathleen McCarroll, (unknown), John P. Quinn, Robert A. Weinstein, Joseph W. Chow	9
8	In Vitro Susceptibilities of Escherichia coli Isolated from Patients with Intra-Abdominal Infections Worldwide in 2002–2004: Results from SMART (Study for Monitoring Antimicrobial Resistance Trends) 2006 ·Surgical Infections ·Grant V. Bochicchio, Fernando Baquero, Po‐Ren Hsueh, David L. Paterson, Flávia Rossi, (unknown), Kathleen McCarroll, Vilas Satishchandran, Mark J. DiNubile, Joseph W. Chow	24
9	In Vitro Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli Isolated from Patients with Intra- Abdominal Infections Worldwide: The 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART) 2005 ·Surgical Infections ·Joseph W. Chow, Vilas Satishchandran, (unknown), Charlotte M. Harvey, Ian R. Friedland, Mark J. DiNubile	52
10	Purification, crystallization and preliminary X-ray analysis ofEnterococcus faeciumaminoglycoside-2′′-phosphotransferase-Ib [APH(2′′)-Ib] 2005 ·Acta Crystallographica Section F Structural Biology and Crystallization Communications ·(unknown), Paul G. Young, Heather M. Baker, Edward N. Baker, Peter Metcalf, Joseph W. Chow, Stephen Lerner, Sergei B. Vakulenko, Clyde A. Smith	5
11	In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART) 2005 ·Journal of Antimicrobial Chemotherapy ·David L. Paterson, Flávia Rossi, Fernando Baquero, Po‐Ren Hsueh, Gail L. Woods, Vilas Satishchandran, (unknown), Charlotte M. Harvey, Hedy Teppler, Mark J. DiNubile, Joseph W. Chow	157
12	In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2”)-Id gene 2000 ·Diagnostic Microbiology and Infectious Disease ·Vivek Kak, (unknown), Marcus Zervos, Reiko Kariyama, Hiromi Kumon, Joseph W. Chow	10
13	In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus☆ 2000 ·Diagnostic Microbiology and Infectious Disease ·(unknown), Reiko Kariyama, Marcus Zervos, Hiromi Kumon, Joseph W. Chow	23
14	Aminoglycoside Resistance in Enterococci 2000 ·Clinical Infectious Diseases ·Joseph W. Chow	234
15	In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci 1998 ·Diagnostic Microbiology and Infectious Disease ·Joseph W. Chow, Susan Donabedian, Don B. Clewell, Daniel F. Sahm, Marcus Zervos	13
16	Emergence of Increased Resistance to Quinupristin/ Dalfopristin During Therapy for Enterococcus faecium Bacteremia 1997 ·Clinical Infectious Diseases ·Joseph W. Chow, (unknown), Marcus Zervos	78
17	Early clinical experience with the multi-link coronary stent 1996 ·Catheterization and Cardiovascular Diagnosis ·(unknown), Chi‐Ming Wong, Chun‐Ho Cheng, Patrick Ko, Joseph W. Chow, (unknown), Christopher Barnes	18
18	Synergy assessed by checkerboard a critical analysis 1993 ·Diagnostic Microbiology and Infectious Disease ·Michael H. Hsieh, (unknown), Victor L. Yu, Joseph W. Chow	182
19	Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia 1993 ·The Lancet ·F. L. Brancati, Joseph W. Chow, Marilyn M. Wagener, (unknown), Victor L. Yu	108
20	Group A Streptococcal Meningitis 1992 ·Clinical Infectious Diseases ·Joseph W. Chow, R. R. Muder	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact